Clik here to view.
Leading Immunologists Gather in New Delhi to Confront Celiac Disease
CAMBRIDGE, Mass. & NEW DELHI The International Society for the Study of Celiac Disease (ISSCD), a non-profit organization of professionals working in the field of celiac disease and...
View ArticleClik here to view.
Sosei: First Subject Dosed in Phase1 Clinical Study of Novel Selective...
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today reported that Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, announces that the first healthy...
View ArticleClik here to view.
Yamaha Motor Releases the Cell Picking & Imaging System CELL HANDLER(TM)
IWATA, Japan Yamaha Motor Co., Ltd. (TOKYO:7272) (ISIN:JP3942800008) announced today that it has developed the cell picking/imaging system CELL HANDLERTM. This device performs part of the testing...
View ArticleClik here to view.
Taro Announces Joining of CEO
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the Company as its Chief Executive Officer (“CEO”)...
View ArticleClik here to view.
Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development...
MISSISSAUGA, Ontario Therapure Biopharma Inc. (“Therapure” or the “Company”) today announced that a joint venture between 3SBio Inc. (HKG:1530) (“3SBio”), a leading global biotechnology company, and...
View ArticleClik here to view.
1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC) today announced that it has recruited and treated its first patient in a randomised, controlled clinical trial of...
View ArticleClik here to view.
重篤な先天性心疾患の新生児スクリーニングにおける研究で、スマートデバイス併用型パルスオキシメーターMasimo iSpO2® Rxの性能を評価
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、マーストリヒトの研究者らが最近発表した研究の知見について発表しました。オランダの研究者らは、重篤な先天性心疾患（CCHD）の新生児スクリーニングにおけるMasimo iSpO2® Rxの性能を評価しました1。iSpO2 RxはMasimo Measure-through Motion and Low...
View ArticleClik here to view.
搭配Masimo iSpO2® Rx智能设备的脉搏氧饱和度仪在新生儿危重型先天性心脏病筛查中的功效研究
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了近期发表的一项研究成果，荷兰马斯特里赫特的研究人员在该研究中评估了Masimo iSpO2® Rx在新生儿危重型先天性心脏病(CCHD)筛查中的功效1。iSpO2 Rx是搭配智能设备的脉搏氧饱和度仪，搭载Masimo移动和低灌注下测量™脉搏氧饱和度技术。...
View ArticleClik here to view.
LAC-Shield™, Morinaga Milk’s New “Immunogenics” Ingredient, Offers...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced that its recently launched “Immunogenics” ingredient LAC-Shield will now be marketed...
View ArticleClik here to view.
森永乳业新款“免疫原性”成分LAC-Shield™，向各家制造商提供经过临床验证的免疫功效和保鲜稳定性
东京 (美国商业资讯) — 日本领先的乳制品公司森永乳业株式会社(TOKYO:2264)今天宣布，该公司新近上市的“免疫原性”成分LAC-Shield现在将在海外推广。该产品是有益杆菌乳酸杆菌(Lactobacillus paracasei MCC1849)的热灭活菌株，临床显示具有增强免疫功能的益处。由于LAC-Shield经过巴氏消毒，它不会产生传统益生菌的稳定性问题。...
View ArticleClik here to view.
ImmusanT Presents Data from Multiple Studies Supporting Continued Development...
CAMBRIDGE, Mass. ImmusanT, Inc., a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet...
View ArticleClik here to view.
Research Definitively Confirms Superiority of ReCell® for Treatment of Burn...
VALENCIA, Calif. & PERTH, Australia & LONDON The ReCell® Autologous Cell Harvesting Device effectively reduces the amount of skin harvesting required relative to conventional treatment of...
View ArticleClik here to view.
Kaneka Eurogentec Announces the Construction of a New Large Scale...
SERAING, Belgium Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced today that its board has approved the construction of a...
View ArticleClik here to view.
Aurigene, a Wholly Owned Subsidiary of Dr. Reddy’s, and Curis Announce CA-170...
BANGALORE, India Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and a specialized biotechnology company...
View ArticleClik here to view.
Kaneka Eurogentec宣布新建一家药品级生物制剂量产制造厂
比利时瑟兰 (美国商业资讯) — Kaneka Eurogentec是一家定制服务商，也是经FDA认可的合同开发和制造组织(CDMO)，该公司今天宣布，其董事会已核准在其现有工厂毗邻新建一家配置2200升发酵器的一流GMP工厂。此次扩建用于重组蛋白、抗体片段和质粒DNA等生物制剂的量产。 回应当前市场需求的新厂...
View ArticleClik here to view.
Seqirus Donates Influenza Vaccine for Hurricane Harvey Relief in Texas
HOLLY SPRINGS, N.C. As hurricane recovery efforts continue in Texas, the U.S. Department of Health and Human Services (DHHS), has requested urgent support to help displaced residents fight the onset...
View ArticleClik here to view.
Poxel Presents Results for Imeglimin Phase 2b Study in Japan for the...
LYON, France POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative therapies for metabolic disorders, including type 2 diabetes, announced...
View ArticleClik here to view.
カネカユーロジェンテックが医薬品グレードバイオ医薬品の新しい大規模製造施設の建設を発表
ベルギー・セラン （ビジネスワイヤ） — カスタムサービスを提供するFDA査察済み医薬品開発製造受託機関（CDMO）のカネカユーロジェンテックは本日、現在の施設に隣接し2200 Lの発酵槽を備えた最先端GMP適合施設の新設を取締役会が承認したと発表しました。施設拡充により、組み換えタンパク質、抗体フラグメント、プラスミドDNAを含むバイオ医薬品の大規模生産が可能になります。...
View ArticleClik here to view.
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER...
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) announced today that the Phase 3 PROSPER trial evaluating XTANDI®...
View ArticleClik here to view.
H3 Biomedicine to Present New Data on H3B-6527, an FGFR4 Inhibitor, at the...
CAMBRIDGE, Mass. H3 Biomedicine Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisai’s global...
View Article